Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor

Journal of Psychopharmacology

Volumn 26, Issue 11, 2012, Pages 1480-1488

  Brown, Russell W ^a   Hughes, Benjamin A ^a   Hughes, Andrew B ^a   Sheppard, A Brianna ^a   Perna, Marla K ^a   Ragsdale, W Lee ^a   Roeding, Ross L ^a   Pond, Brooks B ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

adolescent; behavioral sensitization; brain derived neurotrophic factor; Methylphenidate; rats; ritalin; sex differences; striatum

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHYLPHENIDATE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; FEMALE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORPUS STRIATUM; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

EID: 84867497979     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112454227     Document Type: Article

References (65)

1. Andersen SL, Teicher MH. Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev. 2000 ; 24: 137-141
2. Andersen SL, Thompson AP, Krenzel E, et al. Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology. 2002 ; 27: 683-691
3. Banerjee PS, Aston J, Khundakar AA, et al. Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain. Eur J Neurosci. 2009 ; 29: 465-476
4. Becker JB. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav. 1999 ; 64: 803-810
5. Berridge CW, Devilbiss DM, Andrzejewski ME, et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 2006 ; 60: 1111-1120
6. Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000 ; 14: 2919-2293
7. Biederman J, Faraone SV, Spencer T, et al. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res. 1994 ; 53: 13-29
8. Bolaños CA, Nestler EJ. Neurotrophic mechanisms in drug addiction. Neuromolecular Med. 2004 ; 5: 69-83
9. Booze RM, Welch MA, Wood ML, et al. Behavioral sensitization following repeated intravenous nicotine administration: gender differences and gonadal hormones. Pharmacol Biochem Behav. 1999 ; 64: 827-839
10. Brenhouse HC, Napierata L, Kussmaul L, et al. Juvenile methylphenidate exposure and factors that influence incentive processing. Dev Neurosci. 2009 ; 31: 95-106
11. Bright GM. Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey. Medscape J Med. 2008 ; 10: 111
12. Brown RW, Perna MK, Schaefer TL, et al. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole. Synapse. 2006 ; 59: 253-259
13. Browne RG, Segal DS. Metabolic and experimental factors in the behavioral response to repeated amphetamine. Pharmacol Biochem Behav. 1977 ; 6: 545-552
14. Castner SA, Xiao L, Becker JB. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res. 2006 ; 610: 127-134
15. Chase T, Carrey N, Soo E, et al. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience. 2007 2007 ; 144: 969-984
16. Chelaru MI, Yang PB, Dafny N. Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD). Behav Brain Res. 2012 ; 226: 8-17
17. Dafny N, Yang PB. The role of age, genotype, sex, and route of acute and chronic administration of methylphenidate: a review of its locomotor effects. Brain Res Bull. 2006 ; 68: 393-405
18. Devilbiss DM, Berridge CW. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. J Pharmacol Exp Ther. 2006 ; 319: 1327-1335
19. Dow-Edwards D. Sex differences in the effects of cocaine abuse across the life span. Physiol Behav. 2010 ; 100: 208-215
20. Dupont RL, Coleman JJ, Bucher RH, et al. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. Am J Addict. 2008 ; 17: 167-171
21. Ernst M, Liebenauer LL, King AC, et al. Reduced brain metabolism in hyperactive girls. J Am Acad Child Psy. 1994 ; 33: 858-868
22. Festa ED, Russo SJ, Gazi FM, et al. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology. 2004 ; 46: 672-687
23. Filip M, Faron-Górecka A, Kuśmider M, et al. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res. 2006 ; 1071: 218-225
24. Fumagalli F, Cattaneo A, Caffino L, et al. Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res. 2010 ; 62: 523-529
25. Gawin FH. Cocaine addiction: psychology and neurophysiology. Science. 1991 ; 251: 1580-1586
26. Gerasimov MR, Franceschi M, Volkow ND, et al. Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study. J Pharmacol Exp Ther. 2000 ; 295: 51-57
27. Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA. 1998 ; 279: 1100-1107
28. Graham DL, Edwards S, Bachtell RK, et al. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci. 2007 ; 10: 1029-1037
29. Griffiths RR, Troisi JR, Silverman K, et al. Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol. 1993 ; 4: 3-13
30. Grilly DM, Salamone JM Drugs and Human Behavior. Upper Saddle River, NJ: Prentice-Hall ; 2005 :
31. Grimm JW, Lu L, Hayashi T, et al. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci. 2003 ; 23: 742-747
32. Harrod SB, Mactutus CF, Bennett K, et al. Sex differences and repeated intravenous nicotine: behavioral sensitization and dopamine receptors. Pharmacol Biochem Behav. 2004 ; 78: 581-592
33. Holson RR, Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol. 1992 ; 14: 221-228
34. Horger BA, Iyasere CA, Berhow MT, et al. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci. 1999 ; 19: 4110-4122
35. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001 ; 24: 677-673
36. Kenny PJ, File SE, Rattray M. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res. 2000 ; 85: 234-238
37. Kimko H, Cross J, Abernethy D. Pharmacokinetics and clinical effectiveness of methyphenidate. Clin Pharmacokinet. 1999 ; 37: 457-470
38. Klein-Schwartz W, McGrath J. Poison centers' experience with methylphenidate abuse in preteens and adolescents. J Am Acad Child Adolesc Psych. 2003 ; 42: 288-294
39. Kucenski R, Segal DS. Exposure of adolescent rats to oral methylphenidate: effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci. 2002 ; 22: 264-271
40. McGinty JF, Whitfield TW, Berglind WJ. Brain-derived neurotrophic factor and cocaine addiction. Brain Res. 2010 ; 1314: 183-193
41. Mayes R, Bagwell C, Erkulwater J. ADHD and the rise in stimulant use among children. Harv Rev Psychiatry. 2008 ; 16: 151-166
42. Parran TV, Jasinski DR. Intravenous methylphenidate abuse: prototype for prescription drug abuse. Arch Intern Med. 1991 ; 151: 781-783
43. Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997 ; 25: 192-216
44. Polanczyk G, De Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007 ; 164: 942-948
45. Rivest R, Falardeau P, Di Paolo T, et al. Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res. 1995 ; 692: 269-272
46. Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 1986 ; 396: 157-198
47. Rucklidge JJ. Gender differences in attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2010 ; 33: 357-373
48. Scherer EB, Da Cunha MJ, Matté C, et al. Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat. Neurobiol Learn Mem. 2010 ; 94: 247-253
49. Scheres A, Milham PM, Knutson B, et al. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007 ; 61: 720-724
50. Schuelke GS, Konkol RJ, Terry LC, et al. Effect of cocaine metabolites on behavior: possible neuroendocrine mechanisms. Brain Res Bull. 1996 ; 39: 43-48
51. Schweri MM, Skolnick P, Rafferty MF, et al. [3H]Threo-(+/-)- methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J Neurochem. 1985 ; 45: 1062-1070
52. Sheppard B, Lehmann J, Cope ZA, et al. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes. Behav Neurosci. 2009 ; 123: 1296-1308
53. Smith RF. Animal models of periadolescent substance abuse. Neurotoxicol Teratol. 2003 ; 25: 291-301
54. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res. 1998 ; 94: 127-152
55. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 2000 ; 24: 417-463
56. Tripp G, Wickens JR. Neurobiology of ADHD. Neuropharmacology. 2009 ; 57: 579-89
57. Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003 ; 160: 909-918
58. Volkow ND, Wang GJ, Fowler JS, et al. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sciences. 1999 ; 65: PL7 - PL12
59. Walker QD, Rooney MB, Wightman RM, et al. Dopamine release and uptake are greater in female than male rat striatum as measured by fast cyclic voltammetry. Neuroscience. 2000 ; 95: 1061-1070
60. Warren BL, Iñiguez SD, Alcantara LF, et al. Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J Neurosci. 2011 ; 31: 10347-10358
61. Wilens TE, Boellner SW, López FA, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008 ; 47: 21-31
62. Wooters TE, Dwoskin LP, Bardo MT. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology. 2006 ; 188: 18-27
63. Yang PB, Swann AC, Dafny N. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull. 2006 2006 ; 71: 301-310
64. Zito J. Five burning questions. J Dev Behav Pediatr. 2002 ; 23 (S1). S23 - S30
65. Zito JM, Safer DJ, dosReis S, et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000 ; 283: 1025-1030